<bill session="117" type="h" number="2071" updated="2023-01-11T13:48:07Z">
  <state datetime="2021-03-18">REFERRED</state>
  <status>
    <introduced datetime="2021-03-18"/>
  </status>
  <introduced datetime="2021-03-18"/>
  <titles>
    <title type="display">Medicare Prescription Drug Price Negotiation Act of 2021</title>
    <title type="official" as="introduced">To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.</title>
    <title type="short" as="introduced">Medicare Prescription Drug Price Negotiation Act of 2021</title>
  </titles>
  <sponsor bioguide_id="W000800"/>
  <cosponsors>
    <cosponsor bioguide_id="C001066" joined="2021-03-18"/>
    <cosponsor bioguide_id="C001084" joined="2021-03-18"/>
    <cosponsor bioguide_id="G000574" joined="2021-03-18"/>
    <cosponsor bioguide_id="G000551" joined="2021-03-18"/>
    <cosponsor bioguide_id="L000562" joined="2021-03-18"/>
    <cosponsor bioguide_id="M000087" joined="2021-03-18"/>
    <cosponsor bioguide_id="M001143" joined="2021-03-18"/>
    <cosponsor bioguide_id="P000597" joined="2021-03-18"/>
    <cosponsor bioguide_id="P000607" joined="2021-03-18"/>
    <cosponsor bioguide_id="R000599" joined="2021-03-18"/>
    <cosponsor bioguide_id="S000510" joined="2021-07-21"/>
    <cosponsor bioguide_id="W000797" joined="2021-03-18"/>
  </cosponsors>
  <actions>
    <action datetime="2021-03-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-03-18" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-03-18">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-03-18">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-03-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="2881" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
  </subjects>
  <amendments/>
  <summary date="2021-06-01T13:55:41Z" status="Introduced in House">Medicare Prescription Drug Price Negotiation Act of 2021

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding&#160;prices for drugs covered&#160;under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.</summary>
</bill>
